Generex Biotechnology Corporation (GNBT) Receives Approval From the Ministry of Health of the United Arab Emirates to Sell Generex Oral-Lyn Drug
Generex Biotechnology Corporation (GNBT), the leader in drug delivery for metabolic diseases affecting the inner lining of the mouth, announced that the Ministry of Health of the United Arab Emirates has issued a non-object letter regarding the importation of Generax's Oral-lyn drug. The Manager of United Arab Emirates indicated that the importation of Generex's Oral-lyn drug can be accomplished through the issuance of a purchase order from the Imperial College London Diabetes Centre. The Imperial College London Diabetes Centre is a leading diabetes treatment and resource center, supported by the Zayed Military Hospital. This Centre is currently treating approximately 5,000…